与高脂肪饮食相关的消化系统癌症:机制,基于天然产品的疗法和药物开发
Jia Ma1, Yuanhao Zhang1, Jing Du1
1TCM Prevention and Treatment of Metabolic and Chronic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China.
概括
天然产品通过准多种途径,显示出对抗高脂肪饮食相关的消化道癌症 (HFDDC) 的巨大潜力. 这些化合物为HFDDC预防和治疗提供了有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 营养科学 营养科学
背景情况:
- 摄入高脂肪饮食是发展消化系统癌症的重要危险因素.
- 传统中医提供了丰富的天然产品 (NP) 来源,具有已证明的抗癌特性.
研究的目的:
- 综合审查天然产品 (NP),针对高脂肪饮食相关的消化系统癌症 (HFDDC).
- 阐明NP的多目标机制,以在HFDDC中发现潜在的药物.
主要方法:
- 在主要数据库 (PubMed,科学网,临床试验.gov,欧盟临床试验注册) 进行系统的文献搜索.
- 关键词包括天然产品,高脂肪饮食,消化系统癌症和特定的NP名称.
主要成果:
- 通过调节炎症 (STAT3,WNT通路),脂质代谢 (SREBP,PKCα/Rac1),氧化应激 (NRF2,COX-2) 和免疫监测,NP对HFDDC表现出多重向效应.
- 某些特定的NP如黄素,柏柏林,糖酸,罗斯马林酸,柳科,沙利酸,基因,加罗-糖和益生菌显示出治疗潜力.
- 临床试验证实NP如柏柏林,黄素,烯和鱼油具有抗癌和脂质调节作用.
结论:
- 自然产品显示出通过多目标机制预防和治疗HFDDC的巨大潜力.
- 这些发现为NP在HFDDC管理中的临床转化提供了基础.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
614
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
614
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Chronic Pancreatitis II: Collaborative Care
286
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
286
Inflammatory Bowel Disease IV: Pharmacological Management
445
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
445


